Alan A Musso

CIK 1295830 · Chief Financial Officer · last filed 2026-02-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

47

Lifetime Open-Market Net

-$1.45M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
FULC Chief Financial Officer $3.45 $0 5 2026-02-04
RNTX Director $0.96 $0 1 2025-07-23
Rein Therapeutics, Inc. (ALRN) Delisted Director $2.11 $0 3 2024-12-06
BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted CFO and Treasurer 26,548 $0.07 $2.0K -$1.45M 14 2018-07-05

Recent Filings · Page 4 of 5

47 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2010-10-28 Mixed -$75.9K
2010-10-26 Mixed -$198.0K
2010-05-19 Mixed -$243.3K
2010-01-21 Grant (A) $0
2009-12-17 Mixed -$220.4K
2009-12-15 Mixed -$736.1K
2009-09-09 Mixed -$106.5K
2009-09-01 Mixed -$76.5K
2009-08-26 Mixed -$29.5K
2009-08-17 Mixed -$52.9K
Showing 3140 of 47
Page 4 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.